Company News

FDA Sends Warning Letter To Topical Pain Treatment Maker

Agency flags claims made for roll-on and gel products.

Author Image

By: Christine Esposito

Editor-in-Chief

The US FDA has issued a warning letter to Nutra Pharma Corp. for illegally marketing unapproved products labeled as homeopathic with claims about their ability to treat addiction and chronic pain, including pain associated with cancer, diabetes, shingles, fibromyalgia and other serious conditions. The products included topical treatments as well as an oral spray. Specifically, FDA issued a warning letter to Nutra Pharma for:  “Nyloxin Oral Spray,” “Nyloxin Topical Gel,” ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters